Abstract
It is well documented that impaired DNA damage repair (DDR) induces genomic instability that can efficiently increase the sensitivity of prostate cancer (PCa) cells to PARP inhibitors; however, the underlying mechanism remains elusive. Here, we found profound genomic instability in PCa cells with SPOP gene mutations and confirmed the sensitivity of SPOP -mutated PCa cells to olaparib-induced apoptosis. Mechanistically, we identified olaparib-induced CK2-mediated phosphorylation of PIAS1-S468, which in turn mediated SUMOylation of SPOP, thus promoting its E3 ligase activity in the DDR. Moreover, an abnormal CK2/PIAS1/SPOP axis due to SPOP mutations or defects in CK2-mediated phosphorylation of PIAS1, as well as SPOP inhibitor treatment, led to impaired DDR, thus increasing olaparib-induced apoptosis of PCa cells and enhancing olaparib sensitivity in animal models and patient-derived organoids. This suggested that disruption of the CK2/PIAS1/SPOP signaling axis could serve as an indicator for targeted therapy of PCa using a PARP inhibitor.
Funding Information
  • National Natural Science Foundation of China (32270821)
  • the National Natural Science Foundation of Zhejiang (LY24C050001)
  • the National Natural Science Foundation of Zhejiang (LTGY24H160005)
  • The Youth Science and Technology Innovation Leader of Ningbo (2023QL052)
  • K. C. Wong Magna Fund in Ningbo University (Not Applicable)
  • The Ningbo Clinical Research Center for Urological Disease (2019A21001)
  • the Ningbo Top Medical and Health Research Program (2022020203)
  • Zhejiang Engineering Research Center of Innovative technologies and diagnostic and therapeutic equipment for urinary system diseases (Not Applicable)

This publication has 46 references indexed in Scilit: